Home › Non-Hodgkin Lymphoma › Rhode Island › Providence
Non-Hodgkin Lymphoma clinical trials in Providence, RI
5 studies for Non-Hodgkin Lymphoma are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
RecruitingPhase 1/2
- Local Institution - 0045, Providence
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 1
- Lifespan Cancer Institute at Rhode Island Hospital, Providence
Study of SGR-1505 in Mature B-Cell Neoplasms
RecruitingPhase 1
- Rhode Island Hospital, Providence
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Providence
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
RecruitingPhase 1/2
- Rhode Island Hospital, Providence
Non-Hodgkin Lymphoma trials in other cities
- New York City, NY31 studies
- Houston, TX31 studies
- Boston, MA26 studies
- Nashville, TN21 studies
- Philadelphia, PA20 studies
- Baldwin Park, CA19 studies
- Washington, DC18 studies
- Milwaukee, WI18 studies
- Chicago, IL18 studies
- Atlanta, GA18 studies
- Columbus, OH18 studies
- Dallas, TX17 studies
Other studies in Providence
- Ovarian Cancer15 studies
- Endometrial Cancer14 studies
- Obesity14 studies
- Non-Small Cell Lung Cancer12 studies
- Cancer (all types)12 studies
- Crohn's Disease12 studies
- Breast Cancer11 studies
- Ulcerative Colitis11 studies
- Acute Myeloid Leukemia10 studies
- Metastatic Cancer9 studies
- Overweight9 studies
- Alcohol Use Disorder (AUD)8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.